Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Biotech
Pfizer lets its RSV pipeline dry up in crowded space
Pfizer’s RSV pipeline appears to have run dry of candidates following the cessation of work on both an oral medicine and an RSV-flu combo vaccine.
James Waldron
Oct 29, 2024 11:23am
Pfizer taps Triana to find molecular glues for cancer and more
Oct 15, 2024 10:05am
Pfizer axes another RSV med picked up in $525M ReViral buy
Oct 8, 2024 4:58pm
Biopharma layoff rate stabilizes in Q3: Fierce Biotech analysis
Oct 4, 2024 3:50pm
ESMO: Pfizer sees weight gain in cancer patients, plots ph. 3
Sep 14, 2024 8:45am
Acepodia, Pfizer click together for chemistry-based cell therapy
Sep 3, 2024 5:00pm
